Evidence map›Paper›PMID 36979566›Full record

ArticleBiosensors2023

Development of Gold-Nanoparticle-Based Lateral Flow Immunoassays for Rapid Detection of TB ESAT-6 and CFP-10.

Palesa Pamela Seele, Busiswa Dyan, Amanda Skepu, Charlotte Maserumule, Nicole Remaliah Samantha Sibuyi

Open access · goldFull text read
In one paragraph

Article in Biosensors, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. (Cu-S)Mikrochimica acta · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Palesa Pamela SeeleNanotechnology Innovation Centre, Health Platform, Advanced Materials Division, Mintek, Private Bag X3015, Randburg, Johannesburg 2125, South Africa.
Busiswa DyanNanotechnology Innovation Centre, Health Platform, Advanced Materials Division, Mintek, Private Bag X3015, Randburg, Johannesburg 2125, South Africa.
Amanda SkepuAdvanced Chemistry and Life Sciences Division, Next Generation Health Cluster, Council for Scientific and Industrial Research (CSIR), Pretoria 0001, South Africa.ORCID 0000-0001-8121-5617
Charlotte MaserumuleNanotechnology Innovation Centre, Health Platform, Advanced Materials Division, Mintek, Private Bag X3015, Randburg, Johannesburg 2125, South Africa.
Nicole Remaliah Samantha SibuyiNanotechnology Innovation Centre, Health Platform, Advanced Materials Division, Mintek, Private Bag X3015, Randburg, Johannesburg 2125, South Africa.ORCID 0000-0001-7175-5388
Mintek · ZACouncil for Scientific and Industrial Research · ZA

Funding

Mintek ADR-42305National research foundation (NRF) 128105
6 · The paper itself

Abstract

The current study reports on the development of a rapid and cost-effective TB-antigen diagnostic test for the detection of

Indexed as

Metal NanoparticlesMycobacterium tuberculosisAntibodiesAntigens, BacterialBacterial ProteinsGoldImmunoassayAntibodiesAntigens, BacterialBacterial ProteinsGoldCFP-10ESAT-6immunoassaypoint of carerapid diagnostic testtuberculosis

Identifiers

PMID36979566
PMCPMC10046134
OpenAlexW4323361645

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read1
measurements read44
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.